Senhwa Biosciences, Inc.

Total Valuation

Senhwa Biosciences, Inc. carries a market capitalization of 4.02B, placing it among publicly traded companies globally. Its enterprise value stands at 3.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Senhwa Biosciences, Inc. currently has 89.39M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 3,672.42, and the price-to-book ratio stands at 6.21.

Enterprise Valuation

Financial Position

Senhwa Biosciences, Inc. maintains a current ratio of 17.21, meaning it holds 17.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.91, indicating elevated leverage, while an interest coverage ratio of -369.53 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Senhwa Biosciences, Inc.'s stock has gained approximately 33.72957% over the past 52 weeks. The 50-day moving average sits at 50.13, while the 200-day moving average is 45.98.

Income Statement

Over the trailing twelve months, Senhwa Biosciences, Inc. generated 1.07M in revenue and converted that into -264.77M in net income, yielding earnings per share of -2.96. EBITDA reached -278.26M, while operating income came in at -278.26M.

Balance Sheet

Senhwa Biosciences, Inc. holds 771.78M in cash and equivalents against 22.12M in total debt, resulting in a net debt position of -771.78M. Total book value stands at 632.89M, with working capital of 735.06M providing operational flexibility.

Cash Flow

Senhwa Biosciences, Inc. produced -248.46M in operating cash flow over the past twelve months. After subtracting -280,000.00 in capital expenditures, free cash flow totaled -248.74M - equivalent to -2.79 per share.

Margins

Senhwa Biosciences, Inc. operates with a gross margin of 48.60, reflecting its pricing power and cost economics. The operating margin of -26,005.51 and net profit margin of -24,744.77 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Senhwa Biosciences, Inc.'s most recent stock split took place on August 21, 2020 with a 1000:1021 split ratio.

Scores

Senhwa Biosciences, Inc. posts an Altman Z-Score of 39.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.